Fresenius Medical Care


Advancing in kidney care

11/07/19 -"The US government’s announcement has brought some clarity about how care might be provided in the future. As administration is involved, it still seems to be a long time before implementation. ..."

Pages
44
Language
English
Published on
11/07/19
You may also be interested by these reports :
18/07/19
Getinge reported good Q2 19 numbers – beating top-line estimates and meeting bottom-line estimates. Net sales were up 4% on an organic basis – driven ...

18/07/19
EssilorLuxottica is considering a takeover of Dutch eyewear retailer, GrandVision. Although the deal seems a good strategic fit, given GrandVision’s ...

11/07/19
Every now and then we bring to the fore a handful of pair trades.  This is the summary of how previous Long Short suggestions (on 02/05) panned out: ...

11/07/19
The US government’s announcement has brought some clarity about how care might be provided in the future. As administration is involved, it still ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO